Harmony Biosciences Holdings, Inc. (HRMY) P/E ratio

P/E ratio today
10.9×

Harmony Biosciences Holdings, Inc. (HRMY) trades at 10.9× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 13.8×. That is 0.7% higher than the 13.7× of fiscal 2024. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
10.9×
P/E ratio, fiscal 2025
13.8×
Change on fiscal 2024
+0.7%
Highest on record
73.5×fiscal 2021
Lowest on record
13.7×fiscal 2024
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Harmony Biosciences Holdings, Inc. P/E ratio, in more detail

Today's figure is 20.8% below the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 73.5× in fiscal 2021 and the lowest 13.7× in fiscal 2024. Today's P/E ratio is at or below every one of the 5 fiscal year-ends on record; their median is 15.2×.

History · 5 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Harmony Biosciences Holdings, Inc. P/E ratio, year by year

Harmony Biosciences Holdings, Inc. (HRMY) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today10.9×—$33.01—
202513.8× 0.7% up$37.42$2.71
202413.7× 9.6% down$34.41$2.51
202315.2× 18.3% down$32.30$2.13
202218.6× 74.8% down$55.10$2.97
202173.5×—$42.64$0.58
2020——$36.15-$2.48
2019———-$24.07

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on HRMY

Harmony Biosciences Holdings, Inc., figure by figure

Harmony Biosciences Holdings, Inc. (HRMY) overview: price, valuation and scorecard

Harmony Biosciences Holdings, Inc. P/E ratio: questions and answers

What is Harmony Biosciences Holdings, Inc.'s P/E ratio?

Harmony Biosciences Holdings, Inc. (HRMY) trades at 10.9× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 13.8×. That is 0.7% higher than the 13.7× of fiscal 2024.

Is Harmony Biosciences Holdings, Inc.'s P/E ratio high or low compared with its own history?

Today's P/E ratio is at or below every one of the 5 fiscal year-ends on record; their median is 15.2×.

What are the highest and lowest P/E ratio figures on record for Harmony Biosciences Holdings, Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 73.5× in fiscal 2021 and the lowest 13.7× in fiscal 2024.

How is Harmony Biosciences Holdings, Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Harmony Biosciences Holdings, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Harmony Biosciences Holdings, Inc. (HRMY) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/HRMY/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.